key: cord-0974180-r69s0bya
authors: Lu, Yang
title: DOTATATE -Avid Bilateral Axilla and Subpectoral Lymphadenopathy Induced From COVID-19 mRNA Vaccination Visualized on PET/CT
date: 2021-04-02
journal: Clin Nucl Med
DOI: 10.1097/rlu.0000000000003697
sha: 0ffee6c51a9b2e5a43835f7b9173432966adc2de
doc_id: 974180
cord_uid: r69s0bya

A 64-year-old woman with malignant carcinoid tumor of the ileum received right ileocolectomy 9 years ago. Series follow-up imaging studies including most recent (68)Ga-DOTATATE PET/CT scan in June 2020 have been negative for disease. Current (68)Ga-DOTATATE PET/CT scan showed new cluster of bilateral axillary and subpectoral lymphadenopathy with normal CT morphology, but with avid DOTATATE uptake. There was no other abnormal DOTATATE-avid lesion or suspicious CT image findings. The medical history revealed that the patient received 2 doses of COVID-19 (coronavirus disease 2019) mRNA vaccine at bilateral upper arm deltoid muscles at 21 and 42 days prior to the PET/CT examination, respectively.

This case showed that COVID-19 mRNA vaccination could not only induce new DOTATATE avidity in preexisting axillary lymph node (the right axillary fatty lymph node), but also induce new DOTATATE-avid ipsilateral axillary and subpectoral lymph nodes. Such immune response-induced DOTATATE avidity can be detected up to 42 days after vaccination. This phenomenon suggests a systemic immune-mediated response to the COVID-19 mRNA vaccine, probably similar to that reported in other RNA cancer vaccination. 7 As millions of people are receiving COVID-19 mRNA vaccination, 8 it is important for physicians to understand that such vaccination can induce reactive lymph nodes with either FDG avidity or DOTATATE avidity and avoid false interpretation.

Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine

COVID-19 mRNA vaccination-induced lymphadenopathy mimics lymphoma progression on FDG PET/CT

FDG uptake in axillary lymph nodes after vaccination against pandemic (H1N1)

Axillary lymph node accumulation on FDG-PET/CT after influenza vaccination

Duration of 18 F-FDG avidity in lymph nodes after pandemic H1N1v and seasonal influenza vaccination

False-positive axillary lymph node on FDG-PET/CT scan resulting from immunization

In vivo imaging of the immune response upon systemic RNA cancer vaccination by FDG-PET

Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine